je.st
news
Home
› PeptiDream Announces Collaboration And License Agreement With Lilly To Discover Macrocyclic Peptide Drug Candidates
PeptiDream Announces Collaboration And License Agreement With Lilly To Discover Macrocyclic Peptide Drug Candidates
2013-12-30 05:48:10| drugdiscoveryonline News Articles
PeptiDream Inc, a Tokyo-based biopharmaceutical company (PeptiDream), recenlty announced that they have entered into a Collaboration and License Agreement with US-based Eli Lilly and Company (Lilly) on 19 December 2013
Tags: agreement
license
drug
discover
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||